SNDL, Inc. Q3 FY2026 earnings call

• Financial Discipline: Achieved record quarterly free cash flow of $20 million and returned to positive adjusted operating income ($5.2 million) despite market pressures.
• Cannabis Operations Restructuring: Exited the unprofitable domestic dried flower category to focus on higher-value products. Implemented workforce reductions (>30%) at the Kelowna facility to reduce costs, with P&L benefits expected in Q4.
• Strategic Review: Initiated a review of Cannabis Operations to evaluate strategic alternatives, including potential asset divestitures and productivity initiatives.
• U.S. Investment Progress: Increased indirect equity ownership in Parallels from ~67% to ~92% via rights offering. Funded investments for a new cultivation facility in Gainesville, Florida, and acquired take-back debt at a discount.
• Ontario Regulatory Resolution: Anticipated resolution with the Alcohol and Gaming Commission of Ontario involving a $200,000 penalty. This would transition operations to a modified franchise structure, leading to deconsolidation of Ontario operations from SNDL’s financial statements.
• Capital Allocation: Repurchased 5.4 million shares for $10 million in Q3. Announced intention for a substantial issuer bid of up to $50 million. Maintained a debt-free balance sheet while selectively investing in high-conviction opportunities.

Net revenue was $238 million, a decrease of 2.5% year-over-year. Gross profit was $57.9 million (margin 24.3%).

• Liquor Retail: Net revenue $134.8 million (down 3.3% YoY). Gross profit $36.4 million (margin expanded to record 27.0%). Adjusted operating income $6 million.
• Cannabis Retail: Net revenue $85.6 million (up 0.7% YoY, record). Gross profit $23.1 million (margin expanded to record 27.0%). Adjusted operating income $5.3 million.
• Cannabis Operations: Net revenue $27.0 million (down 27.7% YoY). Gross profit -$1.6 million (negative margin). Adjusted operating loss $11.4 million.

• Free Cash Flow: Expected to receive a second and final $8 million cash inflow in Q4 2026 from the complete unwinding of the captive insurance arrangement.
• Cost Savings: Management expects P&L benefits from workforce reductions and cost controls in Cannabis Operations to begin contributing in Q4 2026.
• No Specific Revenue/Income Targets: No specific forward-looking guidance provided for full-year or next-quarter revenue or net income figures.

• Cannabis Operations Underperformance: Continued below-expectation results in cannabis operations, driven by inventory adjustments and exit costs from the dried flower segment.
• Regulatory Risks: Ongoing regulatory matters in Ontario; although a resolution is anticipated, it involves structural changes and penalties.
• Market Contraction: Same-store sales declined in both liquor retail (-6%) and cannabis retail (-3.8%) due to softness in market demand and contraction in Alberta and Ontario.
• Goodwill Impairment: Recorded a $52 million non-cash goodwill impairment associated with cannabis operations.

Q: Analyst asked about the financial materiality of achieving EU-GMP certification at the Athelbill facility and its impact on international opportunities. / A: CEO stated that while eliminating processor costs (20-45 cents/gram) is beneficial, the primary focus is on facility upgrades (lights, HVAC) to improve quality and yields. These improvements are critical for realizing better pricing in international markets, rather than just cost savings alone.

Q: Analyst inquired why SNDL exited the domestic dried flower category and if this impacts sales in other categories like edibles or beverages. / A: CEO explained that indoor dried flower production is too costly compared to competitors with large-scale hybrid glasshouse infrastructure. SNDL lacks this low-cost advantage but holds a dominant position in edibles and beverages, which operate independently. The exit allows focus on areas where SNDL has competitive advantages.

Q: Analyst asked about core competencies needed to win in cannabis operations and what options are being considered in the strategic review. / A: CFO identified commercial execution and operational efficiency as key priorities. He noted that while infrastructure exists, labor efficiencies and planning processes need improvement. All options, including asset divestitures, are under consideration as management seeks to maximize value from existing assets.

Q: Analyst questioned the dynamics required to deploy capital into the U.S. market, specifically regarding consolidation of medical vs. recreational assets. / A: CEO confirmed SNDL can currently deploy capital via Sunstream JV. The next step is consolidating medical exposure into recurring P&L. Recreational assets may be ring-fenced indirectly to facilitate an up-listing, given current Schedule III clarity issues, but SNDL will not wait for government action to proceed with controllables.